These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 28131897

  • 1. Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer.
    Beaver LM, Kuintzle R, Buchanan A, Wiley MW, Glasser ST, Wong CP, Johnson GS, Chang JH, Löhr CV, Williams DE, Dashwood RH, Hendrix DA, Ho E.
    J Nutr Biochem; 2017 Apr; 42():72-83. PubMed ID: 28131897
    [Abstract] [Full Text] [Related]

  • 2. Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.
    Beaver LM, Buchanan A, Sokolowski EI, Riscoe AN, Wong CP, Chang JH, Löhr CV, Williams DE, Dashwood RH, Ho E.
    Mol Nutr Food Res; 2014 Oct; 58(10):2001-13. PubMed ID: 25044704
    [Abstract] [Full Text] [Related]

  • 3. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
    Xu C, Shen G, Chen C, Gélinas C, Kong AN.
    Oncogene; 2005 Jun 30; 24(28):4486-95. PubMed ID: 15856023
    [Abstract] [Full Text] [Related]

  • 4. Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits.
    Vyas AR, Moura MB, Hahm ER, Singh KB, Singh SV.
    J Cell Biochem; 2016 Nov 30; 117(11):2482-95. PubMed ID: 26990292
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy.
    Vyas AR, Hahm ER, Arlotti JA, Watkins S, Stolz DB, Desai D, Amin S, Singh SV.
    Cancer Res; 2013 Oct 01; 73(19):5985-95. PubMed ID: 23921360
    [Abstract] [Full Text] [Related]

  • 7. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells.
    Pei Y, Wu B, Cao Q, Wu L, Yang G.
    Toxicol Appl Pharmacol; 2011 Dec 15; 257(3):420-8. PubMed ID: 22005276
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
    Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E.
    Mol Nutr Food Res; 2011 Jul 15; 55(7):999-1009. PubMed ID: 21374800
    [Abstract] [Full Text] [Related]

  • 9. Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.
    Vyas AR, Singh SV.
    Eur J Nutr; 2014 Apr 15; 53(3):843-52. PubMed ID: 24092501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
    Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW.
    Int J Oncol; 2004 Jan 15; 24(1):187-92. PubMed ID: 14654956
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA.
    Eur Urol; 2014 Jun 15; 65(6):1140-51. PubMed ID: 24373479
    [Abstract] [Full Text] [Related]

  • 14. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
    Nair S, Barve A, Khor TO, Shen GX, Lin W, Chan JY, Cai L, Kong AN.
    Acta Pharmacol Sin; 2010 Sep 15; 31(9):1223-40. PubMed ID: 20729872
    [Abstract] [Full Text] [Related]

  • 15. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.
    Wong CP, Hsu A, Buchanan A, Palomera-Sanchez Z, Beaver LM, Houseman EA, Williams DE, Dashwood RH, Ho E.
    PLoS One; 2014 Sep 15; 9(1):e86787. PubMed ID: 24466240
    [Abstract] [Full Text] [Related]

  • 16. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells.
    Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC.
    Int J Oncol; 2002 Mar 15; 20(3):631-6. PubMed ID: 11836580
    [Abstract] [Full Text] [Related]

  • 17. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
    Tian H, Zhou Y, Yang G, Geng Y, Wu S, Hu Y, Lin K, Wu W.
    Oncol Rep; 2016 Sep 15; 36(3):1361-8. PubMed ID: 27430422
    [Abstract] [Full Text] [Related]

  • 18. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
    Herman-Antosiewicz A, Xiao H, Lew KL, Singh SV.
    Mol Cancer Ther; 2007 May 15; 6(5):1673-81. PubMed ID: 17513615
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
    Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK, Singh SV.
    Carcinogenesis; 2007 Jan 15; 28(1):151-62. PubMed ID: 16920735
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.